Literature DB >> 22556410

Detrimental role for human high temperature requirement serine protease A1 (HTRA1) in the pathogenesis of intervertebral disc (IVD) degeneration.

André N Tiaden1, Marina Klawitter, Vanda Lux, Ali Mirsaidi, Gregor Bahrenberg, Stephan Glanz, Lilian Quero, Thomas Liebscher, Karin Wuertz, Michael Ehrmann, Peter J Richards.   

Abstract

Human HTRA1 is a highly conserved secreted serine protease that degrades numerous extracellular matrix proteins. We have previously identified HTRA1 as being up-regulated in osteoarthritic patients and as having the potential to regulate matrix metalloproteinase (MMP) expression in synovial fibroblasts through the generation of fibronectin fragments. In the present report, we have extended these studies and investigated the role of HTRA1 in the pathogenesis of intervertebral disc (IVD) degeneration. HTRA1 mRNA expression was significantly elevated in degenerated disc tissue and was associated with increased protein levels. However, these increases did not correlate with the appearance of rs11200638 single nucleotide polymorphism in the promoter region of the HTRA1 gene, as has previously been suggested. Recombinant HTRA1 induced MMP production in IVD cell cultures through a mechanism critically dependent on MEK but independent of IL-1β signaling. The use of a catalytically inactive mutant confirmed these effects to be primarily due to HTRA1 serine protease activity. HTRA1-induced fibronectin proteolysis resulted in the generation of various sized fragments, which when added to IVD cells in culture, caused a significant increase in MMP expression. Furthermore, one of these fragments was identified as being the amino-terminal fibrin- and heparin-binding domain and was also found to be increased within HTRA1-treated IVD cell cultures as well as in disc tissue from patients with IVD degeneration. Our results therefore support a scenario in which HTRA1 promotes IVD degeneration through the proteolytic cleavage of fibronectin and subsequent activation of resident disc cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22556410      PMCID: PMC3375554          DOI: 10.1074/jbc.M112.341032

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  Low back pain in relation to lumbar disc degeneration.

Authors:  K Luoma; H Riihimäki; R Luukkonen; R Raininko; E Viikari-Juntura; A Lamminen
Journal:  Spine (Phila Pa 1976)       Date:  2000-02-15       Impact factor: 3.468

2.  A fibronectin fragment induces type II collagen degradation by collagenase through an interleukin-1-mediated pathway.

Authors:  Tadashi Yasuda; A Robin Poole
Journal:  Arthritis Rheum       Date:  2002-01

3.  A cross-sectional study correlating lumbar spine degeneration with disability and pain.

Authors:  C K Peterson; J E Bolton; A R Wood
Journal:  Spine (Phila Pa 1976)       Date:  2000-01-15       Impact factor: 3.468

4.  Fibronectin and its fragments increase with degeneration in the human intervertebral disc.

Authors:  T R Oegema; S L Johnson; D J Aguiar; J W Ogilvie
Journal:  Spine (Phila Pa 1976)       Date:  2000-11-01       Impact factor: 3.468

Review 5.  Current understanding of cellular and molecular events in intervertebral disc degeneration: implications for therapy.

Authors:  A J Freemont; A Watkins; C Le Maitre; M Jeziorska; J A Hoyland
Journal:  J Pathol       Date:  2002-04       Impact factor: 7.996

6.  The HtrA1 serine protease is down-regulated during human melanoma progression and represses growth of metastatic melanoma cells.

Authors:  Alfonso Baldi; Antonio De Luca; Monica Morini; Tullio Battista; Armando Felsani; Feliciano Baldi; Caterina Catricalà; Ada Amantea; Douglas M Noonan; Adriana Albini; Pier Giorgio Natali; Daniela Lombardi; Marco G Paggi
Journal:  Oncogene       Date:  2002-09-26       Impact factor: 9.867

7.  A web-accessible complete transcriptome of normal human and DMD muscle.

Authors:  Marina Bakay; Po Zhao; Josephine Chen; Eric P Hoffman
Journal:  Neuromuscul Disord       Date:  2002-10       Impact factor: 4.296

8.  A fibronectin fragment stimulates intervertebral disc degeneration in vivo.

Authors:  D Greg Anderson; Xudong Li; Tony Tannoury; Gina Beck; Gary Balian
Journal:  Spine (Phila Pa 1976)       Date:  2003-10-15       Impact factor: 3.468

9.  Developmentally regulated expression of mouse HtrA3 and its role as an inhibitor of TGF-beta signaling.

Authors:  Jiraporn Tocharus; Akiho Tsuchiya; Miwa Kajikawa; Yoshifumi Ueta; Chio Oka; Masashi Kawaichi
Journal:  Dev Growth Differ       Date:  2004-06       Impact factor: 2.053

10.  A candidate tumor suppressor HtrA1 is downregulated in ovarian cancer.

Authors:  Jeremy Chien; Julie Staub; Shou-Ih Hu; Michele R Erickson-Johnson; Fergus J Couch; David I Smith; Robert M Crowl; Scott H Kaufmann; Viji Shridhar
Journal:  Oncogene       Date:  2004-02-26       Impact factor: 9.867

View more
  31 in total

1.  Angiographic features of transgenic mice with increased expression of human serine protease HTRA1 in retinal pigment epithelium.

Authors:  Sandeep Kumar; Zachary Berriochoa; Balamurali K Ambati; Yingbin Fu
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-05-22       Impact factor: 4.799

2.  Simvastatin Inhibits IL-1β-Induced Apoptosis and Extracellular Matrix Degradation by Suppressing the NF-kB and MAPK Pathways in Nucleus Pulposus Cells.

Authors:  Ji Tu; Wentian Li; Yukun Zhang; Xinghuo Wu; Yu Song; Liang Kang; Wei Liu; Kun Wang; Shuai Li; Wenbin Hua; Cao Yang
Journal:  Inflammation       Date:  2017-06       Impact factor: 4.092

Review 3.  Biochemical composition and turnover of the extracellular matrix of the normal and degenerate intervertebral disc.

Authors:  Sarit Sara Sivan; Anthony J Hayes; Ellen Wachtel; Bruce Caterson; Yulia Merkher; Alice Maroudas; Sharon Brown; Sally Roberts
Journal:  Eur Spine J       Date:  2013-04-17       Impact factor: 3.134

Review 4.  Organ culture bioreactors--platforms to study human intervertebral disc degeneration and regenerative therapy.

Authors:  Benjamin Gantenbein; Svenja Illien-Jünger; Samantha C W Chan; Jochen Walser; Lisbet Haglund; Stephen J Ferguson; James C Iatridis; Sibylle Grad
Journal:  Curr Stem Cell Res Ther       Date:  2015       Impact factor: 3.828

5.  Expression and regulation of toll-like receptors (TLRs) in human intervertebral disc cells.

Authors:  Marina Klawitter; Michiyuki Hakozaki; Hiroshi Kobayashi; Olga Krupkova; Lilian Quero; Caroline Ospelt; Steffen Gay; Oliver Hausmann; Thomas Liebscher; Ullrich Meier; Miho Sekiguchi; Shin-ichi Konno; Norbert Boos; Stephen J Ferguson; Karin Wuertz
Journal:  Eur Spine J       Date:  2014-07-05       Impact factor: 3.134

6.  Chondroadherin fragmentation mediated by the protease HTRA1 distinguishes human intervertebral disc degeneration from normal aging.

Authors:  Bashar Akhatib; Patrik Onnerfjord; Rahul Gawri; Jean Ouellet; Peter Jarzem; Dick Heinegård; John Mort; Peter Roughley; Lisbet Haglund
Journal:  J Biol Chem       Date:  2013-05-14       Impact factor: 5.157

7.  Fibronectin fragments and the cleaving enzyme ADAM-8 in the degenerative human intervertebral disc.

Authors:  Nancy Ruel; Dessislava Z Markova; Sherrill L Adams; Carla Scanzello; Gabriella Cs-Szabo; David Gerard; Peng Shi; D Greg Anderson; Marc Zack; Howard S An; Di Chen; Yejia Zhang
Journal:  Spine (Phila Pa 1976)       Date:  2014-07-15       Impact factor: 3.468

Review 8.  Syndecan-4 in intervertebral disc and cartilage: Saint or synner?

Authors:  Abbie L A Binch; Irving M Shapiro; Makarand V Risbud
Journal:  Matrix Biol       Date:  2016-01-18       Impact factor: 11.583

9.  Expression and activity of hyaluronidases HYAL-1, HYAL-2 and HYAL-3 in the human intervertebral disc.

Authors:  Olga Krupkova; Helen Greutert; Norbert Boos; Johannes Lemcke; Thomas Liebscher; Karin Wuertz-Kozak
Journal:  Eur Spine J       Date:  2019-11-22       Impact factor: 3.134

10.  Nerve Growth Factor Is Regulated by Toll-Like Receptor 2 in Human Intervertebral Discs.

Authors:  Emerson Krock; J Brooke Currie; Michael H Weber; Jean A Ouellet; Laura S Stone; Derek H Rosenzweig; Lisbet Haglund
Journal:  J Biol Chem       Date:  2015-12-14       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.